These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 34265137)
21. Why must the debate continue on Krabbe disease newborn screening? Pike-Langenfeld S Am J Med Genet C Semin Med Genet; 2022 Jun; 190(2):153-155. PubMed ID: 36056676 [TBL] [Abstract][Full Text] [Related]
22. Dangerous and expensive screening and treatment for rare childhood diseases: the case of Krabbe disease. Lantos JD Dev Disabil Res Rev; 2011; 17(1):15-8. PubMed ID: 22447750 [TBL] [Abstract][Full Text] [Related]
23. International approaches for delivery of positive newborn bloodspot screening results for CF. Chudleigh J; Ren CL; Barben J; Southern KW J Cyst Fibros; 2019 Sep; 18(5):614-621. PubMed ID: 31047829 [TBL] [Abstract][Full Text] [Related]
24. Genetic Counselors' Experience with and Opinions on the Management of Newborn Screening Incidental Carrier Findings. Leppert K; Bisordi K; Nieto J; Maloney K; Guan Y; Dixon S; Egense A J Genet Couns; 2018 Dec; 27(6):1328-1340. PubMed ID: 29687313 [TBL] [Abstract][Full Text] [Related]
25. Newborn screening for Pompe disease: Parental experiences and follow-up care for a late-onset diagnosis. Prakash S; Penn JD; Jackson KE; Dean LW J Genet Couns; 2022 Dec; 31(6):1404-1420. PubMed ID: 35915971 [TBL] [Abstract][Full Text] [Related]
26. A qualitative secondary evaluation of statewide follow-up interviews for abnormal newborn screening results for cystic fibrosis and sickle cell hemoglobinopathy. La Pean A; Collins JL; Christopher SA; Eskra KL; Roedl SJ; Tluczek A; Farrell MH Genet Med; 2012 Feb; 14(2):207-14. PubMed ID: 22261754 [TBL] [Abstract][Full Text] [Related]
27. Parents' experiences 12 years after newborn screening for genetic susceptibility to type 1 diabetes and their attitudes to whole-genome sequencing in newborns. Kerruish N Genet Med; 2016 Mar; 18(3):249-58. PubMed ID: 26066540 [TBL] [Abstract][Full Text] [Related]
28. Parental attitudes toward ethical and social issues surrounding the expansion of newborn screening using new technologies. Hasegawa LE; Fergus KA; Ojeda N; Au SM Public Health Genomics; 2011; 14(4-5):298-306. PubMed ID: 20689248 [TBL] [Abstract][Full Text] [Related]
29. A tailored approach to family-centered genetic counseling for cystic fibrosis newborn screening: the Wisconsin model. Tluczek A; Zaleski C; Stachiw-Hietpas D; Modaff P; Adamski CR; Nelson MR; Reiser CA; Ghate S; Josephson KD J Genet Couns; 2011 Apr; 20(2):115-28. PubMed ID: 20936425 [TBL] [Abstract][Full Text] [Related]
30. Healthcare professionals' and parents' experiences of the confirmatory testing period: a qualitative study of the UK expanded newborn screening pilot. Moody L; Atkinson L; Kehal I; Bonham JR BMC Pediatr; 2017 May; 17(1):121. PubMed ID: 28482885 [TBL] [Abstract][Full Text] [Related]
31. Consent for newborn screening: the attitudes of health care providers. Miller FA; Hayeems RZ; Carroll JC; Wilson B; Little J; Allanson J; Bytautas JP; Paynter M; Christensen R; Chaktraborty P Public Health Genomics; 2010; 13(3):181-90. PubMed ID: 19776551 [TBL] [Abstract][Full Text] [Related]
32. Newborn Screening for Krabbe Disease: Status Quo and Recommendations for Improvements. Matern D; Basheeruddin K; Klug TL; McKee G; Edge PU; Hall PL; Kurtzberg J; Orsini JJ Int J Neonatal Screen; 2024 Jan; 10(1):. PubMed ID: 38390974 [TBL] [Abstract][Full Text] [Related]
34. Clinical outcomes of children with abnormal newborn screening results for Krabbe disease in New York State. Wasserstein MP; Andriola M; Arnold G; Aron A; Duffner P; Erbe RW; Escolar ML; Estrella L; Galvin-Parton P; Iglesias A; Kay DM; Kronn DF; Kurtzberg J; Kwon JM; Langan TJ; Levy PA; Naidich TP; Orsini JJ; Pellegrino JE; Provenzale JM; Wenger DA; Caggana M Genet Med; 2016 Dec; 18(12):1235-1243. PubMed ID: 27171547 [TBL] [Abstract][Full Text] [Related]
35. Consensus recommendations for the classification and long-term follow up of infants who screen positive for Krabbe Disease. Thompson-Stone R; Ream MA; Gelb M; Matern D; Orsini JJ; Levy PA; Rubin JP; Wenger DA; Burton BK; Escolar ML; Kurtzberg J Mol Genet Metab; 2021; 134(1-2):53-59. PubMed ID: 33832819 [TBL] [Abstract][Full Text] [Related]
36. Providers' Perspectives Related to Parents' Choice of Pediatric Provider of Record and Newborn Screening: A Qualitative Study. Lowe T; Boyd J; Shu L; DeLuca JM J Prim Care Community Health; 2023; 14():21501319231190274. PubMed ID: 37522551 [TBL] [Abstract][Full Text] [Related]
37. Exploring the Stories of Parents' Experiences With Infant Hearing-Loss Screening and Diagnosis in the United States. Robinson TL; Bowman EB; Barker BA Ear Hear; 2023 May-Jun 01; 44(3):518-529. PubMed ID: 36534640 [TBL] [Abstract][Full Text] [Related]
38. Newborn Screening for Krabbe Disease and Identification of Minority Patients. Bonkowsky JL; Wilkes J; Baker M; Grantham A; Kurtzberg J; Orsini J Pediatr Neurol; 2024 Feb; 151():65-67. PubMed ID: 38103524 [No Abstract] [Full Text] [Related]
39. Newborn screening for Krabbe disease: the New York State model. Duffner PK; Caggana M; Orsini JJ; Wenger DA; Patterson MC; Crosley CJ; Kurtzberg J; Arnold GL; Escolar ML; Adams DJ; Andriola MR; Aron AM; Ciafaloni E; Djukic A; Erbe RW; Galvin-Parton P; Helton LE; Kolodny EH; Kosofsky BE; Kronn DF; Kwon JM; Levy PA; Miller-Horn J; Naidich TP; Pellegrino JE; Provenzale JM; Rothman SJ; Wasserstein MP Pediatr Neurol; 2009 Apr; 40(4):245-52; discussion 253-5. PubMed ID: 19302934 [TBL] [Abstract][Full Text] [Related]
40. Weighing the evidence for newborn screening for early-infantile Krabbe disease. Kemper AR; Knapp AA; Green NS; Comeau AM; Metterville DR; Perrin JM Genet Med; 2010 Sep; 12(9):539-43. PubMed ID: 20601893 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]